AstraZeneca Admits Vaccine Can Cause Rare Blood Clot Side Effect
AstraZeneca has admitted for the first time that its COVID-19 vaccine can cause a rare blood clot side effect. The company made the admission in court documents related to a class-action lawsuit filed in the UK. The lawsuit alleges that the vaccine caused death and serious injury, including TTS (Thrombosis with Thrombocytopenia Syndrome).
 |
| News source The Tribune |
TTS is a serious condition that can cause blood clots and low platelet levels. It is a very rare side effect of the AstraZeneca vaccine, and the benefits of the vaccine far outweigh the risks.
What is TTS?
TTS is a serious condition that can cause blood clots to form in unusual places in the body, such as the brain, abdomen, or legs. It can also cause low levels of platelets, which are cells that help the blood to clot.
Symptoms of TTS
The symptoms of TTS can appear within a few days to four weeks after receiving the AstraZeneca vaccine. They can include:
- * Severe headache
- * Abdominal pain
- * Back pain
- * Leg pain or swelling
- * Shortness of breath
- * Blurred vision
Should I be worried if I received the AstraZeneca vaccine?
The risk of developing TTS is very low. If you are concerned about the risk of TTS, you should talk to your doctor. They can help you to weigh the risks and benefits of the vaccine.
AstraZeneca, in collabora tion with the University of Oxford, had developed AZD1222 vaccine after the outbreak of the coronavirus in 2020. In India, it was man- ufactured and supplied under the name Covishield by Serum Institute of India (SII) through a licence from the university and the Swedish-British drug maker.
However, doctors say that Indians who took the jab should not be worried.
